Key Takeaways
- SPCX shares finished Friday’s session down 1% at $152.71, even with a fresh $946 million NASA agreement in hand.
- The space company received authorization for three additional crew transport missions, bringing its program tally to 17 flights worth $5.92 billion combined.
- The highly anticipated Starship Flight 14 launch date shifted from September 22 to September 28, awaiting final regulatory clearance.
- Second-quarter financials revealed $7.81 billion in revenue, marking a 92% year-over-year surge.
- Technical analysis from Invezz highlights an ascending triangle formation, while analyst consensus points to a $221.42 target price.
Shares of SpaceX (SPCX) ended Friday’s trading session at $152.71, reflecting a 1.36% decline, after fluctuating within a range of $149.93 to $156.60 throughout the day. Despite the modest retreat, the stock continues trading significantly higher than its 2026 bottom of $104.83.
Space Exploration Technologies Corp., SPCX
The downward movement occurred despite positive news from NASA, which granted SpaceX three additional astronaut transport missions through its Commercial Crew Transportation initiative. The contract amendment carries a value of $946 million.
According to NASA’s announcement, the newly assigned missions include Crew-15, Crew-16, and Crew-17. This expansion increases SpaceX’s total mission count under the program to 17 contracted flights.
The expanded agreement encompasses comprehensive services including ground operations, launch services, orbital operations, spacecraft return and recovery, cargo delivery capabilities, and emergency backup functions. NASA confirmed the contract’s cumulative value now reaches $5.92 billion.
Expanded NASA Partnership Strengthens Revenue Pipeline
The contractual timeline extends through 2030, with mission launch readiness targets set for 2027 and 2028. SpaceX initially earned NASA certification for crewed spaceflight operations in November 2020.
This contract extension follows SpaceX’s disclosure of $7.81 billion in second-quarter revenue. The figure represents a 91.9% increase compared to the corresponding period in the previous year, based on MarketBeat data.
Financial results showed a quarterly loss of $0.09 per share unit, which outperformed analyst expectations of a $0.26 loss. However, the company continues to operate without positive earnings per share.
Institutional investor activity remains robust. Corient Private Wealth established a fresh stake valued at approximately $5.09 million through the acquisition of 29,814 SPCX share units in the second quarter.
MarketBeat’s analyst coverage compilation shows 26 Buy recommendations, eight Hold ratings, and seven Sell ratings for SpaceX. The consensus price objective sits at $221.42, representing potential upside of roughly 45% from Friday’s close.
Starship Flight 14 Emerges as Critical Catalyst
Market attention now shifts to Starship Flight 14. SpaceX rescheduled the launch window from September 22 to September 28, though the mission remains contingent on receiving regulatory authorization.
The upcoming test flight aims to accomplish Starship’s inaugural orbital mission. Mission parameters call for approximately six complete Earth orbits over a duration approaching 10 hours.
Additionally, SpaceX intends to deploy 26 Starlink V3 satellites as part of the flight. Each next-generation satellite features design specifications enabling one terabit per second of network throughput.
The six-day postponement contributed to selling pressure in SPCX shares during Friday’s session. The company has not issued public commentary explaining the launch date adjustment.
From a technical analysis standpoint, Invezz detected an ascending triangle pattern on the two-hour timeframe chart. The analysis also confirmed SPCX trading above its 50-period moving average and identified $200 as a potential breakout threshold.
SPCX has advanced from approximately $104.60 in August to current levels above $150. Its 50-day moving average presently registers near $134.69, based on MarketBeat tracking.
Looking ahead, the September 28 Starship launch represents the next significant milestone for market participants to monitor. SpaceX emphasizes the mission timeline remains subject to regulatory approval outcomes.


